Increasing concentrations of intravitreal therapies for neovascular age-related macular degeneration. Chew EY. Lancet 2024 Mar 7:S0140-6736(24)00229-0. doi: 10.1016/S0140-6736(24)00229.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chew EY. Increasing concentrations of intravitreal therapies for neovascular age-related macular degeneration. Lancet 2024 Mar 7:S0140-6736(24)00229-0. doi: 10.1016/S0140-6736(24)00229.
PMID: 38461839